Glycolysis Metabolism in Neurodegeneration is a critical component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
Brain glucose metabolism is essential for neuronal function, with glycolysis providing rapid energy and metabolic intermediates. Cerebral glucose hypometabolism is an early hallmark of Alzheimer's disease and contributes to other neurodegenerative conditions. [2]
The glycolytic pathway converts glucose to pyruvate: [3]
| Enzyme | Step | Regulation | [4]
|--------|------|------------| [5]
| Hexokinase (HK) | Glucose → G6P | Inhibited by G6P | [6]
| Phosphofructokinase (PFK) | F6P → F1,6BP | AMP/ATP, citrate | [7]
| Pyruvate kinase (PK) | PEP → Pyruvate | Allosteric activation | [8]
| Change | Effect | [9]
|--------|--------| [10]
| ↓ GLUT1/3 | Reduced glucose uptake |
| ↓ PFK activity | Impaired glycolysis |
| ↓ PDH activity | Reduced acetyl-CoA |
| ↓ Mitochondrial function | Energy failure |
| Finding | Brain Region | Diagnostic Use |
|---|---|---|
| ↓ Glucose metabolism | Posterior cingulate, parietal | FDG-PET biomarker |
| ↓ PFK activity | Cortex, hippocampus | Research |
| ↓ GLUT1/3 | BBB, neurons | Pathology |
| ↑ Lactate | CSF, brain tissue | Biomarker |
| Target | Approach | Status |
|---|---|---|
| GLUT1 | Increase expression | Preclinical |
| PFK activators | Enhance glycolysis | Research |
| Insulin signaling | Intranasal insulin | Clinical trials |
| Ketogenic diet | Alternative fuel | Clinical trials |
| Change | Effect |
|---|---|
| ↓ Complex I | Impaired oxidative phosphorylation |
| ↑ Glycolysis compensation | Metabolic adaptation |
| ↓ Mitochondrial function | ATP depletion |
| ↑ Oxidative stress | Further damage |
| Approach | Rationale |
|---|---|
| Ketogenic diet | Alternative energy |
| Metabolic supplements | Support glycolysis |
| Exercise | Improve metabolism |
| Finding | Implication |
|---|---|
| ↓ Glucose uptake | Energy failure |
| ↑ Resting energy expenditure | Cachexia risk |
| Altered lactate metabolism | ANLS dysfunction |
| Change | Brain Region |
|---|---|
| ↓ Glucose metabolism | Striatum, cortex |
| ↑ Lactate | Basal ganglia |
| ↓ PFK | Motor cortex |
| Compound | Target | Status |
|---|---|---|
| L-carnitine | Fatty acid oxidation | Clinical trials |
| Alpha-lipoic acid | Mitochondrial function | Research |
| CoQ10 | Electron transport chain | Clinical trials |
| Approach | Mechanism | Status |
|---|---|---|
| Ketogenic diet | Ketone as fuel | Clinical trials |
| Ketone esters | Exogenous ketones | Phase I/II |
| MCT oil | Ketone production | Research |
| Target | Approach | Status |
|---|---|---|
| GLUT1 | Gene therapy | Preclinical |
| GLUT3 | Expression enhancers | Research |
| SGLT2 | Glucose regulation | Research |
The study of Glycolysis Metabolism In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
🔴 Low Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 10 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 75% |
Overall Confidence: 39%
Cunnane SC, et al. (2020). Journal of Neurochemistry. 2020. ↩︎
Mergenthaler P, et al. (2013). Trends in Neurosciences. 2013. ↩︎
Pellerin L, Magistretti PJ. (1994). Journal of Cerebral Blood Flow & Metabolism. 1994. ↩︎
Mosconi L, et al. (2008). Neurology. 2008. ↩︎
Hertz L, et al. (2015). Developmental Neuroscience. 2015. ↩︎
Camandola S, Mattson MP. (2017). EMBO Reports. 2017. ↩︎
Zhou Y, et al. (2015). Journal of Alzheimer's Disease. 2015. ↩︎
Arnold SE, et al. (2018). Neurobiology of Disease. 2018. ↩︎
Schön M, et al. (2019). Nutritional Neuroscience. 2019. ↩︎
Yao J, et al. (2011). Journal of Alzheimer's Disease. 2011. ↩︎